Please login to the form below
Democratizing Brain Health with Digital Assessments
Dr. Pam Ventola, Senior Science Director at Cogstate, shares how the company is working to optimize brain health assessments in rare disease and pediatric clinical trials, and how this can help advance the development of new medicines and enable earlier clinical insights. She also discusses cognitive testing as part of decentralized trials, the role of central rating and central scoring, the development of indication-specific COAs for rare disease trials, and much more.
Company Details
Impetus Digital
Address:
Impetus Digital
WaterPark Place
20 Bay Street, 11th Floor
Toronto
Ontario
M5J 2N8
Canada
Latest content on this profile
- The (inevitable) digital transformation of Medical Affairs
- It’s not a question of ‘if,’ it’s a question of ‘when.’
Impetus Digital
- Patient Clinical Trial & Communications Plan Review: A Customer Story
Impetus Digital
- Patient Support Program (PSP) Optimization: A Customer Story
Impetus Digital
- Train your brain for success
- In this episode of Impetus Digital‘s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital sits down with Max Newlon, President of Brain Co. They discuss everything from meditation practices and behavioral science to the use of technology in assessing and treating mental health conditions. They also delve into Brain Co’s different types of offerings, including smart prosthetics and wearables, along with the underlying deep learning algorithms.To find out more about Impetus: https://www.meetwithimpetus.comImpetus Digital Website: https://www.impetusdigital.com/ Max Newlon: https://www.linkedin.com/in/max-newlon-6860a84a/Brain Co: https://www.brainco.tech/
Impetus Digital
- Virtual Patient Steering Committee: A Customer Story
Impetus Digital
- Leveraging virtual tools to get the most out of hybrid congresses
- Tips on how to optimize congress information-gathering...
Impetus Digital
